Discover Great Companies Discover Great Clients
Popularity  25.3万   |   Followers  898   |   Likes  7   |   Feedback  413 Claim this company

A large traditional Chinese medicine enterprise integrating R&D, produ

No.3 Lianyungang City Popularity Ranking No.3 Lianyun District No.96 Jiangsu Pr No.1 Hua Gong / Chemistry No.1 Raw Materials No.2 Sheng Wu Ke Ji / Biotechnology Engineering No.2 Gong Cheng Yan Jiu Center No.3 Pharmaceutical No.3 Lin Chuang Yi Xue No.3 Biopharmaceuticals No.3 Pharmaceutical Industrial No.3 Zhi Yao / Yao Industries Ding Agents Clinical Biotechnology Chemistry Gu Shang Ke Yao 名牌产品 驰名商标 企业技术中心 守合同重信用企业 创新型企业 院士工作站
More

Company Overview

  • Nature: Listed Company Size: 1000-4999 employees Founded: 30年
  • Industry: Pharmaceutical/Bioengineering
  • Full name: Jiangsu Kanion Pharmaceutical Co., Ltd.。

Development Stage

  • Stage: IPO上市, 主板, 上交所。
  • Ranking: Ranked #3 in Lianyungang City by popularity Ranked #1 in Lianyungang Hua Gong / Chemistry Company by popularity Ranked #1 in Lianyungang Raw Materials Company by popularity Ranked #2 in Lianyungang Sheng Wu Ke Ji / Biotechnology Engineering Company by popularity Ranked #2 in Lianyungang Gong Cheng Yan Jiu Center Company by popularity
  • Honors: 2023中国专利实力500强 2022中国企业慈善公益500强 名牌产品 驰名商标 According to algorithm
  • News: 2025-08-18:康缘药业:收到健脾疏肝固本颗粒临床试验批准通知书。
  • Salary: 53.3% of positions earn 6-10K, In 2026 vs last yeargrew by 26%.。Master's salary: ¥13.1K, Doctorate salary: ¥25.0K.
  • R&D: "Medical & Health/Beauty & Healthcare" demand: 6.9%, "Computer/Network/Technology": 6.6%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 1.8%。
  • Recruiting: In 2026 vs 2025grew by 22%. Demand for highly educated talent: Master's: 75, Doctorate: 9.
  • Requirement: Education: 本科 leads with 47.2%. Experience: 1-3年 leads with 46.4%.
  • Region: Distributed across 100 regions, 南京: 18.9%, 连云港: 6.7%, 北京: 4.6%, 广州: 3.1%.

About the Company

[Summary] A large traditional Chinese medicine enterprise integrating R&D, produ

Jiangsu Kanion Pharmaceutical Co., Ltd. is a large-scale traditional Chinese medicine (TCM) enterprise integrating R&D, production, and trade. It is an A-share listed company, recognized as a national key high-tech enterprise, a national innovative pilot enterprise, a national technology innovation demonstration enterprise, a national intellectual property demonstration enterprise, and one of the top 100 Chinese pharmaceutical enterprises (29th). It has established research platforms such as the State Key Laboratory of New Technology for Pharmaceutical Manufacturing of Traditional Chinese Medicine and the National-Local Joint Engineering Research Center for Intelligent Manufacturing of Chinese Patent Medicines. It is one of the Chinese herbal medicine companies with the most new drug certificates and invention patents, and one of the deepest promoters of TCM internationalization.
Kanion Pharmaceutical adheres to institutional and technological innovation, having established a comprehensive Jiangsu Kanion Modern Chinese Medicine Research Institute, with a scientific research team of nearly 500 people, over 70% of whom hold master's or doctoral degrees. To date, it has launched more than 50 modern TCM new drugs, including Guizhi Fuling Capsules, Reduning Injection, Jinzhen Oral Liquid, and Ginkgo Diterpene Lactone Meglumine Injection, which have become well-known brands in gynecological and anti-infective treatment fields. It has undertaken over 50 national science and technology projects, including "973" and "863" projects, international cooperation projects, and major new drug innovation projects, holds nearly 500 authorized invention patents, and has won two second prizes of the National Science and Technology Progress Award, one second prize of the National Technology Invention Award, eight first prizes of provincial and ministerial science and technology progress awards, and two China Patent Gold Awards. It has built China's intelligent TCM production factory, which is a smart manufacturing pilot demonstration project approved by the Ministry of Industry and Information Technology. The TCM intelligent solid preparation factory, upon completion, will fully realize automated, informational, and intelligent control of the entire process from extraction and purification of TCM raw materials to preparation, with strong industry demonstration effect.
Looking to the future, the company will adhere to the core concept of "Premium Chinese Medicine, Created by Kanion," vigorously develop modern TCM, promote its internationalization, steadily expand the broader TCM industry and biopharmaceutical industry, and make greater contributions to high-quality industrial development and human health.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Kanion Pharmaceutical Financing History (1 rounds)

Manage
IPO上市
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Market: 主板
  • Deal: 上交所

Kanion Pharmaceutical How Fast Is Hiring Growing? (1062 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 57%
  • 2024: Up 167%
  • 2023: Up 489%
  • 2022: Down 83%
Kanion Pharmaceutical Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Kanion Pharmaceutical Campus Recruitment & Advanced Degree Talent Demand
Graduates 42 Interns 2 Master's 75 Doctorate 9
No.8
Company Recruitment Ranking in Lianyungang City 򀀩
No.51
Recruitment Growth Ranking in Lianyungang City 򀀩
No.4
Graduate Talent Ranking in Lianyungang City 򀀩
No.6
Intern Talent Ranking in Lianyungang City 򀀩
Note: How fast is hiring at Jiangsu Kanion Pharmaceutical Co., Ltd. growing? Kanion Pharmaceutical2026: 2378 openings (up 22%), 2025: 1957 openings (up 57%), 2024: 1243 openings (up 167%), 2023: 465 openings (up 489%), 2022: 79 openings (down 83%), 2021: 458 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Kanion Pharmaceutical Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Down 28%
  • 2024: Up 114%
  • 2023: Up 514%
  • 2022: Down 59%
Kanion Pharmaceutical Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Jiangsu Kanion Pharmaceutical Co., Ltd. growing? Kanion PharmaceuticalMaster's recruitment over the years: 2025: 66 openings (down 28%), 2024: 92 openings (up 114%), 2023: 43 openings (up 514%), 2022: 7 openings (down 59%), 2021: 17 openings. Kanion Pharmaceutical master talent ranking in Lianyungang: #4, Kanion Pharmaceutical master salary mostly around 8-15K.

Kanion Pharmaceutical Doctoral Degree Job Demand Analysis

(More)
-21%
Growth Rate
2026 vs 2025
  • 2025: Down 36%
  • 2024: Up 175%
Kanion Pharmaceutical Doctoral Hiring by Year: 2026 — 3 fewer jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
No.3
Doctoral Demand Ranking in Lianyungang City 򀀩
¥20-30K
Doctoral Salary 򀀩
How fast is doctoral hiring at Jiangsu Kanion Pharmaceutical Co., Ltd. growing? Kanion PharmaceuticalDoctorate recruitment over the years: 2026: 11 openings (down 21%), 2025: 14 openings (down 36%), 2024: 22 openings (up 175%), 2023: 8 openings. Kanion Pharmaceutical doctorate talent ranking in Lianyungang: #3, Kanion Pharmaceutical doctorate salary mostly around 20-30K.

Kanion Pharmaceutical R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Jiangsu Kanion Pharmaceutical Co., Ltd.? Based on an analysis of Kanion Pharmaceutical's job postings over the past year, "Medical & Health/Beauty & Healthcare" demand: 6.9%, "Computer/Network/Technology": 6.6%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 1.8%, "Art/Design/Creative": 1%, "Other (R&D and Technical)": 0.9%, "Scientific Research": 0.6%. For reference only.

Kanion Pharmaceutical — What Are the Salaries Like? (2524 records)

Manage
Kanion Pharmaceutical Salary Overview
salary range: 4.5K - 50K, 53.3% of roles pay ¥6-10K
Note: salary statistics are based on 2524 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Jiangsu Kanion Pharmaceutical Co., Ltd.?Kanion Pharmaceutical53.3% of positions earn 6-10K, Fresh graduate salary: ¥7.8K。Lianyungang salary ranking top 20,销售类 average salary ¥11.4K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Kanion Pharmaceutical

(More)
Are salaries high at Jiangsu Kanion Pharmaceutical Co., Ltd.? We provide: Pharmaceutical Sales Representative, Leasing Manager, Information, Promotion Specialist, Provincial Manager, 公司经理, Sales, Operations, 临床, Regional Manager, Product Manager, OTC Representative, BP, Account Manager, Retail, Division Manager, Key Account Manager, Accountant, Channel Manager, Analyst. Click to view detailed salary analysis by job.

Kanion Pharmaceutical — Fortune 500? (More)

Yes, ranked in 中国专利实力500强:

  • NO.347 2023中国专利实力500强 >
  • NO.290 2022中国专利实力500强 >
  • NO.206 2020中国专利实力500强 >

Yes, ranked in 中国企业慈善公益500强:

  • NO.358 2022中国企业慈善公益500强 >

Job Category

  • 销售类
    64.2% of total 64.2%
  • 经营管理类
    19.5% of total 19.5%
  • 市场/公关/媒介类
    13.4% of total 13.4%
  • 医疗卫生/美容保健类
    7.7% of total 7.7%

Education

  • 本科
    47.2% of total 47.2%
  • 大专
    43% of total 43%
  • 硕士
    5.5% of total 5.5%
  • 不限
    3.9% of total 3.9%

Experience

  • 1-3年
    46.4% of total 46.4%
  • 不限
    24.3% of total 24.3%
  • 3-5年
    21.5% of total 21.5%
  • 5-10年
    5.9% of total 5.9%
View Detailed Analysis

What does Jiangsu Kanion Pharmaceutical Co., Ltd. require? Who is Kanion Pharmaceutical hiring? Kanion Pharmaceutical recruitment: 销售类占比最多占64.2%,其次是经营管理类占19.5%. What education can get in at Kanion Pharmaceutical? 本科占比最多占47.2%,其次是大专占43%. High education required at Kanion Pharmaceutical? 硕士占5.5%,博士占0.4%. Work experience required at Kanion Pharmaceutical? 1-3年占比最多占46.4%,其次是不限占24.3%. Where are the job locations at Kanion Pharmaceutical? 南京占比最多占18.9%,其次是连云港占6.7%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 56,615.8806万(元)
Legal Representative: 高海鑫
Date Established:
Credit Code: 91320700138997640W
Registered Address: 连云港经济技术开发区江宁工业城

Partners & Suppliers

广安门医院采购康缘药业的中药注射液等产品,并合作开展临床研究。 Source
合作客户 中成药供应商
作为公司主要经销商,采购公司中成药产品进行华东等重点区域分销 Source
合作客户 医药商业/分销
作为公司主要经销商,采购公司中成药产品进行全国分销 Source
合作客户 医药商业/分销
作为公司主要经销商,采购公司中成药产品进行全国分销 Source
合作客户 医药商业/分销
代理桂枝茯苓胶囊等妇科中成药,负责山东医疗机构推广 Source
合作客户 中成药

People who follow Kanion Pharmaceutical also follow

Kanion Pharmaceutical Competitors (Similar Companies)

“Research, development, and production of anti-tumor and surgical medic”
“A renowned enterprise in China's liver disease and anti-tumor fields”
方便面 茶饮料 饮品 碳酸饮料
“Supplier of optical fibre preforms, optical fibres, and optical cables”
生命科学 生物信息 生物制药 干细胞
“Integrated solution provider in infrastructure sector”
分立器件 半导体 芯片封装测试 生产
品牌管理 品牌策划 营销服务 创新服务
“Supplier of multifunctional automotive emergency jump starter solution”
物流/运输 货运 律师事务所/法律服务 网络
“Beijing Lianjia Real Estate Brokerage Co., Ltd. is a data-driven, valu”
制药/药业 医药 医药中间体 仿制药
皮革 箱包 生产 研发
智慧城市 物联网/IoT 安防/安全防范 智慧交通
驱动控制 测量设备 直流有刷 电机驱动

Discover Great Companies, Discover Great Clients

连云港公司名录 连云港“Lianyun District”公司名录 连云港“制药/药业”公司名录 连云港“医药工业”公司名录 连云港“医药”公司名录 连云港“生物科技/生物工程”公司名录 连云港“生物医药”公司名录 附近的公司

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates